Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
3.050
-0.070 (-2.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $4.60 million as of December 20, 2024. Its market cap has increased by 187.27% in one year.
Market Cap
4.60M
Enterprise Value
-12.54M
1-Year Change
187.27%
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $4.60M, a decrease of -96.85%. That is a compound annual growth rate of -27.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 4.60M | 155.56% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sintx Technologies | 4.82M |
| NuCana | 4.75M |
| Sonnet BioTherapeutics Holdings | 4.69M |
| Bionomics | 4.66M |
| Oragenics | 4.64M |
| Predictive Oncology | 4.60M |
| Biomerica | 4.58M |
| Healthcare Triangle | 4.53M |